DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Recommendation of “Reduce” from Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given a consensus rating of “Reduce” by the fourteen ratings firms that are currently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $14.8333.

Several research analysts recently issued reports on XRAY shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday. Barclays initiated coverage on DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price on the stock. Mizuho increased their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Tuesday. Evercore ISI lowered their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company cut their price target on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors have recently made changes to their positions in XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of DENTSPLY SIRONA in the first quarter valued at approximately $26,000. Goldman Sachs Group Inc. boosted its stake in DENTSPLY SIRONA by 827.3% during the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after buying an additional 2,172,343 shares during the period. Empowered Funds LLC grew its position in DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after buying an additional 1,320 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of DENTSPLY SIRONA by 7.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier’s stock valued at $8,860,000 after acquiring an additional 41,579 shares during the last quarter. Finally, Focus Partners Wealth boosted its position in shares of DENTSPLY SIRONA by 59.1% during the 1st quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier’s stock valued at $376,000 after acquiring an additional 9,355 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $12.73 on Tuesday. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36. DENTSPLY SIRONA has a 12-month low of $9.85 and a 12-month high of $20.59. The company’s 50 day moving average price is $11.52 and its two-hundred day moving average price is $12.89. The firm has a market cap of $2.54 billion, a PE ratio of -2.88, a PEG ratio of 0.98 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The company had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. During the same period in the prior year, the firm earned $0.50 earnings per share. DENTSPLY SIRONA’s revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.0%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.48%.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.